Luke Timmerman
@luketimmerman.bsky.social
Founder & Editor, Timmerman Report.
Next stop: Kilimanjaro 2026 for Damon Runyon Cancer Research Foundation Meet the team of biotech leaders raising $1 million for cancer research and hiking up the highest peak in Africa. timmermanreport.com/2025/09/next...
Next Stop: Kilimanjaro 2026 for Damon Runyon Cancer Research - TimmermanReport.com
The biotech industry can do amazing things when concentrated on an audacious goal. Like curing cancer. I’m fired up to announce the next Timmerman Traverse for Damon Runyon Cancer Research Foundation....
timmermanreport.com
September 9, 2025 at 12:52 PM
Next stop: Kilimanjaro 2026 for Damon Runyon Cancer Research Foundation Meet the team of biotech leaders raising $1 million for cancer research and hiking up the highest peak in Africa. timmermanreport.com/2025/09/next...
Why is Vineeta Agarwala joining the Timmerman Traverse for a 3rd time on Oct. 4? Watch.
September 4, 2025 at 6:35 PM
Why is Vineeta Agarwala joining the Timmerman Traverse for a 3rd time on Oct. 4? Watch.
Timmerman Traverse for Life Science Cares raises another $1.1M to fight poverty. timmermanreport.com/2025/08/timm...
Timmerman Traverse for Life Science Cares Raises Another $1.1M to Fight Poverty in 2025 - TimmermanReport.com
Another Timmerman Traverse for Life Science Cares is in the books. This year, we raised $1.15 million from more than 1,000 donors to fight poverty in biotech hubs around the US. We raised awareness of...
timmermanreport.com
August 25, 2025 at 1:20 PM
Timmerman Traverse for Life Science Cares raises another $1.1M to fight poverty. timmermanreport.com/2025/08/timm...
CAR-T cells against solid tumors. Listen to Sabah Oney, CEO of Dispatch Biotherapeutics, on The Long Run. timmermanreport.com/2025/08/car-...
CAR-T Cells Against Solid Tumors: Sabah Oney on The Long Run - TimmermanReport.com
Sabah Oney is today’s guest on The Long Run. Sabah is the CEO of Philadelphia and San Francisco-based Dispatch Biotherapeutics. This startup is developing engineered CAR-T cell therapies for solid tum...
timmermanreport.com
August 6, 2025 at 1:36 PM
CAR-T cells against solid tumors. Listen to Sabah Oney, CEO of Dispatch Biotherapeutics, on The Long Run. timmermanreport.com/2025/08/car-...
VIDEO: Conversation with Phil Sharp and Bill Haney about 'Cracking the Code.' Documentary film about an inspiring life in science. timmermanreport.com/2025/08/vide...
VIDEO: Phil Sharp and Bill Haney on 'Cracking the Code' - TimmermanReport.com
Science and society have always had an uneasy relationship. Yet there are always people out there seeking to build bridges of understanding. I recently moderated a conversation at MIT with Phil Sharp...
timmermanreport.com
August 5, 2025 at 3:22 PM
VIDEO: Conversation with Phil Sharp and Bill Haney about 'Cracking the Code.' Documentary film about an inspiring life in science. timmermanreport.com/2025/08/vide...
Creative Ways to Back Young Scientists. Listen to Yung Lie and Andy Rachleff of Damon Runyon Cancer Research Foundation on The Long Run podcast. timmermanreport.com/2025/07/crea...
Creative Ways to Back Young Scientists: Andy Rachleff and Yung Lie on The Long Run - TimmermanReport.com
Yung Lie and Andy Rachleff are today’s guests on The Long Run. Yung is the president and CEO of the Damon Runyon Cancer Research Foundation, based in New York. Andy is the board chair. Andy was one of...
timmermanreport.com
July 23, 2025 at 1:40 PM
Creative Ways to Back Young Scientists. Listen to Yung Lie and Andy Rachleff of Damon Runyon Cancer Research Foundation on The Long Run podcast. timmermanreport.com/2025/07/crea...
Sublime scenery. Smiling faces. Thanks to the sponsors of the Timmerman Traverse for Damon Runyon Cancer Research Foundation. Watch this for 90 seconds of joy. www.youtube.com/watch?v=LwzE...
Thank you to the sponsors of the 2025 Timmerman Traverse to Everest Base Camp!
YouTube video by Damon Runyon Cancer Research Foundation
www.youtube.com
June 26, 2025 at 3:09 PM
Sublime scenery. Smiling faces. Thanks to the sponsors of the Timmerman Traverse for Damon Runyon Cancer Research Foundation. Watch this for 90 seconds of joy. www.youtube.com/watch?v=LwzE...
Finding Therapies in Long Non-Coding RNA. John Rinn of University of Colorado and Lincswitch Therapeutics is the latest guest on The Long Run. Available on Apple Podcasts, Spotify, and YouTube. timmermanreport.com/2025/06/find...
Finding Therapies in Long Non-Coding RNA: John Rinn on The Long Run - TimmermanReport.com
John Rinn is today’s guest on The Long Run. John is the Leslie Orgel and Marvin Caruthers professor of RNA science at the University of Colorado in Boulder. His research is focused on long non-coding ...
timmermanreport.com
June 12, 2025 at 1:43 PM
Finding Therapies in Long Non-Coding RNA. John Rinn of University of Colorado and Lincswitch Therapeutics is the latest guest on The Long Run. Available on Apple Podcasts, Spotify, and YouTube. timmermanreport.com/2025/06/find...
Join me at 3 pm Mon. June 16 at the BIO International Convention's Storytelling Stage to hear about the past, present, and future of Timmerman Traverse for @lifesciencecares.bsky.social @damonrunyon.org convention.bio.org/program/bio-...
BIO International Convention | Storytelling Stage
Experience powerful stories from researchers, patients, and innovators at the BIO 2025 Storytelling Stage, June 16–19 in Boston.
convention.bio.org
June 10, 2025 at 11:08 PM
Join me at 3 pm Mon. June 16 at the BIO International Convention's Storytelling Stage to hear about the past, present, and future of Timmerman Traverse for @lifesciencecares.bsky.social @damonrunyon.org convention.bio.org/program/bio-...
Request an Invitation to the Timmerman Traverse. timmermanreport.com/2025/06/requ...
Request an Invitation to the Timmerman Traverse - TimmermanReport.com
Timmerman Traverse is looking for a few good men and women. Opportunities are here for people who are physically fit, enjoy nature, thrive in community, and who want to roll up the sleeves for worthy ...
timmermanreport.com
June 5, 2025 at 1:18 PM
Request an Invitation to the Timmerman Traverse. timmermanreport.com/2025/06/requ...
A New (and Old) Idea for Cardiovascular Disease & Diabetes. @ethanjweiss.bsky.social and Josh Lehrer of Marea Therapeutics are the latest guests on The Long Run. timmermanreport.com/2025/05/a-ne...
A New and Old Idea for Cardiovascular Disease & Diabetes: Ethan Weiss & Josh Lehrer on The Long Run - TimmermanReport.com
Ethan Weiss and Josh Lehrer are today’s guests on The Long Run. Ethan is the co-founder and chief scientific officer of South San Francisco-based Marea Biosciences. Josh is the CEO. They are seeking t...
timmermanreport.com
May 29, 2025 at 1:13 PM
A New (and Old) Idea for Cardiovascular Disease & Diabetes. @ethanjweiss.bsky.social and Josh Lehrer of Marea Therapeutics are the latest guests on The Long Run. timmermanreport.com/2025/05/a-ne...
Reclaiming Biotech's Edge: In Defense of Taking Disciplined Risk. Guest editorial by Anika Gupta Vatsa. timmermanreport.com/2025/05/recl...
May 27, 2025 at 1:17 PM
Reclaiming Biotech's Edge: In Defense of Taking Disciplined Risk. Guest editorial by Anika Gupta Vatsa. timmermanreport.com/2025/05/recl...
Timmerman Traverse for @lifesciencecares.bsky.social is at $535,178 in pending and closed donations. Halfway to the $1M team goal with three months to go. Thanks to major sponsors Fenwick & West, KCap Biotechnology Fund and HSBC Innovation Banking. Looking forward to our PNW adventure!
May 23, 2025 at 3:57 PM
Timmerman Traverse for @lifesciencecares.bsky.social is at $535,178 in pending and closed donations. Halfway to the $1M team goal with three months to go. Thanks to major sponsors Fenwick & West, KCap Biotechnology Fund and HSBC Innovation Banking. Looking forward to our PNW adventure!
Biologic Drug Discovery Made Faster. Peyton Greenside of BigHat Biosciences is the latest guest on The Long Run podcast. timmermanreport.com/2025/05/biol...
Biologic Drug Discovery Made Faster: Peyton Greenside on The Long Run - TimmermanReport.com
Peyton Greenside is today’s guest on The Long Run. Peyton is the co-founder and CEO of San Mateo, Calif.-based BigHat Biosciences. The company was started in 2019 to build on advances in synthetic bio...
timmermanreport.com
May 14, 2025 at 2:51 PM
Biologic Drug Discovery Made Faster. Peyton Greenside of BigHat Biosciences is the latest guest on The Long Run podcast. timmermanreport.com/2025/05/biol...
A Sublime Experience. See the photo highlights of Timmerman Traverse for Damon Runyon Cancer Research Foundation. timmermanreport.com/2025/05/a-su...
A Sublime Experience: Views of Timmerman Traverse for Damon Runyon Cancer Research - TimmermanReport.com
Kathmandu, Nepal We did it together. The Timmerman Traverse for Damon Runyon Cancer Research Foundation completed a splendid expedition to Everest Base Camp on Apr. 23, 2025. This trip succeeded on ev...
timmermanreport.com
May 2, 2025 at 11:15 AM
A Sublime Experience. See the photo highlights of Timmerman Traverse for Damon Runyon Cancer Research Foundation. timmermanreport.com/2025/05/a-su...
We all made it! The Timmerman Traverse for Damon Runyon Cancer Research Foundation team arrived at Everest Base Camp (elev. 17,600 feet) on Apr. 23, 2025. Another awe-inspiring day in the mountains, supporting brave and bold cancer research. Thanks to all who supported this marvelous experience.
April 24, 2025 at 11:11 AM
We all made it! The Timmerman Traverse for Damon Runyon Cancer Research Foundation team arrived at Everest Base Camp (elev. 17,600 feet) on Apr. 23, 2025. Another awe-inspiring day in the mountains, supporting brave and bold cancer research. Thanks to all who supported this marvelous experience.
Views from Day 7 of Timmerman Traverse for Damon Runyon Cancer Research Foundation.
April 21, 2025 at 10:24 AM
Views from Day 7 of Timmerman Traverse for Damon Runyon Cancer Research Foundation.
Stunning views from Timmerman Traverse for Damon Runyon Cancer Research Foundation. Day 5. We’re at Dingboche, elevation 14,300 ft. The Himalayas in full glory.
April 19, 2025 at 9:56 AM
Stunning views from Timmerman Traverse for Damon Runyon Cancer Research Foundation. Day 5. We’re at Dingboche, elevation 14,300 ft. The Himalayas in full glory.
What US Biotech Can Do to Meet the Moment. By David Li, CEO of SF-based Meliora Therapeutics. timmermanreport.com/2025/04/a-ne...
April 10, 2025 at 2:12 PM
What US Biotech Can Do to Meet the Moment. By David Li, CEO of SF-based Meliora Therapeutics. timmermanreport.com/2025/04/a-ne...
Reposted by Luke Timmerman
Great article by @nobelprize.bsky.social laureate @ardemp.bskyverified.social outlining the health, economic and national security benefits of US biomedical research, and the devastation of government efforts to destroy our leading edge.
www.cnn.com/2025/04/09/h...
www.cnn.com/2025/04/09/h...
Nobel laureate: I owe America my success. Today, its scientific future is in danger | CNN
Dr. Ardem Patapoutian says he watches “with deep sadness as the United States’ remarkable scientific enterprise, which took generations of hard work and national investment to build, faces a concerted...
www.cnn.com
April 9, 2025 at 2:30 PM
Great article by @nobelprize.bsky.social laureate @ardemp.bskyverified.social outlining the health, economic and national security benefits of US biomedical research, and the devastation of government efforts to destroy our leading edge.
www.cnn.com/2025/04/09/h...
www.cnn.com/2025/04/09/h...
Dr. Larry Corey was a fan of the Superman comics as a kid. Now he's looking for a hero in a red cape to stand up for mRNA vaccines and therapies. timmermanreport.com/2025/04/we-n...
We Need an mRNA Champion in a Red Cape - TimmermanReport.com
I grew up in an era of Superman comic books. Superman captivated the imagination of a generation of kids like me. It told stories of an otherwise ordinary human who could achieve extraordinary feats o...
timmermanreport.com
April 9, 2025 at 1:30 PM
Dr. Larry Corey was a fan of the Superman comics as a kid. Now he's looking for a hero in a red cape to stand up for mRNA vaccines and therapies. timmermanreport.com/2025/04/we-n...
A favorite sign from the Saturday rally in Seattle.
April 8, 2025 at 1:09 AM
A favorite sign from the Saturday rally in Seattle.
Meet the 2025 Timmerman Traverse for Life Science Cares 2025 team. Men and women on a mission to raise $1 million to fight poverty in BOS, SF, SD, PHI and NYC. Top sponsor: Fenwick & West. CC @robperez.bsky.social timmermanreport.com/2025/04/meet...
Meet the Timmerman Traverse for Life Science Cares 2025 Team - TimmermanReport.com
The 5th annual Timmerman Traverse for Life Science Cares is fired up and ready for outdoor adventure in 2025. We’re on a mission to raise $1 million to fight poverty. This year’s team is preparing fo...
timmermanreport.com
April 7, 2025 at 4:36 PM
Meet the 2025 Timmerman Traverse for Life Science Cares 2025 team. Men and women on a mission to raise $1 million to fight poverty in BOS, SF, SD, PHI and NYC. Top sponsor: Fenwick & West. CC @robperez.bsky.social timmermanreport.com/2025/04/meet...
Goal: the 2025 Timmerman Traverse for Damon Runyon Cancer Research Foundation has hit the fundraising goal of $700,000 for high-risk / high-reward cancer research. Team gearing up for trek to Everest Base Camp. timmermanreport.com/2025/04/timm...
Timmerman Traverse for Damon Runyon Hits $700K Goal, Fueling Cancer Research - TimmermanReport.com
Times are tough in biotech, but this is an industry where we learn, adapt, and move forward. I’m proud to announce that the 2025 Timmerman Traverse for Damon Runyon Cancer Research Foundation has hit ...
timmermanreport.com
April 3, 2025 at 1:21 PM
Goal: the 2025 Timmerman Traverse for Damon Runyon Cancer Research Foundation has hit the fundraising goal of $700,000 for high-risk / high-reward cancer research. Team gearing up for trek to Everest Base Camp. timmermanreport.com/2025/04/timm...